BRISTOL-MYERS SQUIBB CO (BRM.DE) Fundamental Analysis & Valuation

FRA:BRM • US1101221083

Current stock price

50.17 EUR
-0.52 (-1.03%)
Last:

This BRM.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BRM.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BRM was profitable.
  • In the past year BRM had a positive cash flow from operations.
  • BRM had positive earnings in 4 of the past 5 years.
  • BRM had a positive operating cash flow in each of the past 5 years.
BRM.DE Yearly Net Income VS EBIT VS OCF VS FCFBRM.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • The Return On Assets of BRM (7.83%) is comparable to the rest of the industry.
  • BRM's Return On Equity of 38.19% is amongst the best of the industry. BRM outperforms 92.16% of its industry peers.
  • With an excellent Return On Invested Capital value of 19.52%, BRM belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
  • BRM had an Average Return On Invested Capital over the past 3 years of 14.47%. This is in line with the industry average of 13.61%.
  • The last Return On Invested Capital (19.52%) for BRM is above the 3 year average (14.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROIC 19.52%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
BRM.DE Yearly ROA, ROE, ROICBRM.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • BRM has a better Profit Margin (14.64%) than 62.75% of its industry peers.
  • In the last couple of years the Profit Margin of BRM has grown nicely.
  • BRM has a Operating Margin of 35.82%. This is amongst the best in the industry. BRM outperforms 90.20% of its industry peers.
  • BRM's Operating Margin has improved in the last couple of years.
  • BRM has a Gross Margin of 72.63%. This is comparable to the rest of the industry: BRM outperforms 58.82% of its industry peers.
  • In the last couple of years the Gross Margin of BRM has remained more or less at the same level.
Industry RankSector Rank
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
BRM.DE Yearly Profit, Operating, Gross MarginsBRM.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BRM.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BRM is creating value.
  • The number of shares outstanding for BRM has been increased compared to 1 year ago.
  • BRM has less shares outstanding than it did 5 years ago.
  • BRM has a better debt/assets ratio than last year.
BRM.DE Yearly Shares OutstandingBRM.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BRM.DE Yearly Total Debt VS Total AssetsBRM.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 2.52 indicates that BRM is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • BRM has a Altman-Z score (2.52) which is in line with its industry peers.
  • BRM has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as BRM would need 3.51 years to pay back of all of its debts.
  • BRM has a Debt to FCF ratio of 3.51. This is in the better half of the industry: BRM outperforms 62.75% of its industry peers.
  • A Debt/Equity ratio of 2.33 is on the high side and indicates that BRM has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.33, BRM is not doing good in the industry: 80.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Altman-Z 2.52
ROIC/WACC2.22
WACC8.78%
BRM.DE Yearly LT Debt VS Equity VS FCFBRM.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • BRM has a Current Ratio of 1.26. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, BRM is in line with its industry, outperforming 47.06% of the companies in the same industry.
  • BRM has a Quick Ratio of 1.14. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.14, BRM is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.14
BRM.DE Yearly Current Assets VS Current LiabilitesBRM.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BRM.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 439.47% over the past year.
  • The Earnings Per Share has been decreasing by -0.92% on average over the past years.
  • The Revenue has decreased by -0.22% in the past year.
  • BRM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.54% yearly.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • The Earnings Per Share is expected to decrease by -4.15% on average over the next years.
  • The Revenue is expected to decrease by -5.54% on average over the next years.
EPS Next Y2.96%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
EPS Next 5Y-4.15%
Revenue Next Year-1.82%
Revenue Next 2Y-2.01%
Revenue Next 3Y-5.44%
Revenue Next 5Y-5.54%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRM.DE Yearly Revenue VS EstimatesBRM.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
BRM.DE Yearly EPS VS EstimatesBRM.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. BRM.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.59, the valuation of BRM can be described as very reasonable.
  • Based on the Price/Earnings ratio, BRM is valued cheaper than 90.20% of the companies in the same industry.
  • BRM is valuated cheaply when we compare the Price/Earnings ratio to 27.71, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 9.32, which indicates a very decent valuation of BRM.
  • 90.20% of the companies in the same industry are more expensive than BRM, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.09, BRM is valued rather cheaply.
Industry RankSector Rank
PE 9.59
Fwd PE 9.32
BRM.DE Price Earnings VS Forward Price EarningsBRM.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BRM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRM is cheaper than 92.16% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BRM is valued cheaper than 90.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.38
EV/EBITDA 7.25
BRM.DE Per share dataBRM.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRM does not grow enough to justify the current Price/Earnings ratio.
  • BRM has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as BRM's earnings are expected to decrease with -4.23% in the coming years.
PEG (NY)3.25
PEG (5Y)N/A
EPS Next 2Y0.32%
EPS Next 3Y-4.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. BRM.DE Dividend Analysis

5.1 Amount

  • BRM has a Yearly Dividend Yield of 4.27%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.89, BRM pays a better dividend. On top of this BRM pays more dividend than 82.35% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, BRM pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.27%

5.2 History

  • On average, the dividend of BRM grows each year by 6.51%, which is quite nice.
Dividend Growth(5Y)6.51%
Div Incr Years4
Div Non Decr Years4
BRM.DE Yearly Dividends per shareBRM.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • BRM pays out 71.52% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of BRM has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
BRM.DE Yearly Income VS Free CF VS DividendBRM.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
BRM.DE Dividend Payout.BRM.DE Dividend Payout, showing the Payout Ratio.BRM.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BRM.DE Fundamentals: All Metrics, Ratios and Statistics

BRISTOL-MYERS SQUIBB CO

FRA:BRM (4/21/2026, 7:00:00 PM)

50.17

-0.52 (-1.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners83.83%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap102.43B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target53.87 (7.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.27%
Yearly Dividend2.13
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)2.8%
PT rev (3m)10.5%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)-0.94%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)4.46%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)3.34%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)6.73%
Valuation
Industry RankSector Rank
PE 9.59
Fwd PE 9.32
P/S 2.5
P/FCF 9.38
P/OCF 8.51
P/B 6.52
P/tB N/A
EV/EBITDA 7.25
EPS(TTM)5.23
EY10.42%
EPS(NY)5.38
Fwd EY10.73%
FCF(TTM)5.35
FCFY10.66%
OCF(TTM)5.89
OCFY11.74%
SpS20.06
BVpS7.69
TBVpS-9.32
PEG (NY)3.25
PEG (5Y)N/A
Graham Number30.08 (-40.04%)
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROCE 25.91%
ROIC 19.52%
ROICexc 23.22%
ROICexgc 84.94%
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
FCFM 26.65%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Debt/EBITDA 2.03
Cap/Depr 32.69%
Cap/Sales 2.72%
Interest Coverage 8.22
Cash Conversion 66.54%
Profit Quality 182.1%
Current Ratio 1.26
Quick Ratio 1.14
Altman-Z 2.52
F-Score7
WACC8.78%
ROIC/WACC2.22
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.96%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
EPS Next 5Y-4.15%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.82%
Revenue Next 2Y-2.01%
Revenue Next 3Y-5.44%
Revenue Next 5Y-5.54%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.35%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.47%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%

BRISTOL-MYERS SQUIBB CO / BRM.DE Fundamental Analysis FAQ

What is the fundamental rating for BRM stock?

ChartMill assigns a fundamental rating of 5 / 10 to BRM.DE.


What is the valuation status of BRISTOL-MYERS SQUIBB CO (BRM.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (BRM.DE). This can be considered as Undervalued.


Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?

BRISTOL-MYERS SQUIBB CO (BRM.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for BRM stock?

The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (BRM.DE) is 9.59 and the Price/Book (PB) ratio is 6.52.


Can you provide the financial health for BRM stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (BRM.DE) is 5 / 10.